6-7555815-C-T
Position:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_004415.4(DSP):c.268C>T(p.Gln90*) variant causes a stop gained change. The variant allele was found at a frequency of 0.00000124 in 1,613,730 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.0000066 ( 0 hom., cov: 33)
Exomes 𝑓: 6.8e-7 ( 0 hom. )
Consequence
DSP
NM_004415.4 stop_gained
NM_004415.4 stop_gained
Scores
4
2
1
Clinical Significance
Conservation
PhyloP100: 4.84
Genes affected
DSP (HGNC:3052): (desmoplakin) This gene encodes a protein that anchors intermediate filaments to desmosomal plaques and forms an obligate component of functional desmosomes. Mutations in this gene are the cause of several cardiomyopathies and keratodermas, including skin fragility-woolly hair syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 6-7555815-C-T is Pathogenic according to our data. Variant chr6-7555815-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 265102.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DSP | NM_004415.4 | c.268C>T | p.Gln90* | stop_gained | 2/24 | ENST00000379802.8 | NP_004406.2 | |
DSP | NM_001319034.2 | c.268C>T | p.Gln90* | stop_gained | 2/24 | NP_001305963.1 | ||
DSP | NM_001008844.3 | c.268C>T | p.Gln90* | stop_gained | 2/24 | NP_001008844.1 | ||
DSP | NM_001406591.1 | c.268C>T | p.Gln90* | stop_gained | 2/11 | NP_001393520.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DSP | ENST00000379802.8 | c.268C>T | p.Gln90* | stop_gained | 2/24 | 1 | NM_004415.4 | ENSP00000369129.3 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152274Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
1
AN:
152274
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000399 AC: 1AN: 250568Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135480
GnomAD3 exomes
AF:
AC:
1
AN:
250568
Hom.:
AF XY:
AC XY:
0
AN XY:
135480
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461456Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 727034
GnomAD4 exome
AF:
AC:
1
AN:
1461456
Hom.:
Cov.:
32
AF XY:
AC XY:
0
AN XY:
727034
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152274Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74394
GnomAD4 genome
AF:
AC:
1
AN:
152274
Hom.:
Cov.:
33
AF XY:
AC XY:
1
AN XY:
74394
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Apr 25, 2024 | PM2, PS4_moderate, PVS1 - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jan 06, 2025 | Identified in individuals with cardiomyopathy and/or arrhythmia referred for genetic testing at GeneDx and in the published literature (PMID: 32372669); Not observed at significant frequency in large population cohorts (gnomAD); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 30217213, 31402444, 36136372, 29181379, 31847883, 32372669) - |
not specified Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Jul 05, 2018 | The p.Gln90Ter variant is predicted to result in a truncated or absent protein product. This variant has not been reported in the medical literature; however a similar truncating variant (p.Q51Ter) was reported in one individual with Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD), whereby electrical abnormalities on electrocardiography and Holter monitoring were proposed as an indicator for high risk patients (te Riele, 2013). This variant is listed in the Genome Aggregation Database (gnomAD) identified on a single chromosome out of 245,444, and has been reported to the ClinVar database as a pathogenic/likely pathogenic variant (Variation ID: 265102). Based on these observations, the p.Gln90Ter variant is considered to be pathogenic. - |
Arrhythmogenic cardiomyopathy with wooly hair and keratoderma Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | All of Us Research Program, National Institutes of Health | Apr 25, 2024 | This variant changes 1 nucleotide in exon 2 of the DSP gene and is expected to introduce a premature translation stop signal at codon 90. The mutant transcript may undergo nonsense-mediated mRNA decay, resulting in an absent or non-functional protein product. There are multiple in-frame methionines in exon 3 prior to a known functional domain, and it is unknown if any of these methionines may serve as alternate translation initiation site, thereby potentially mitigating the effect of this p.Gln90* variant. This variant has been reported in a family affected with dilated cardiomyopathy or arrhythmogenic cardiomyopathy (PMID: 32372669), in two individuals affected with sudden death (PMID: 29181379, 31847883). This variant has been identified in 1/250568 chromosomes in the general population by the Genome Aggregation Database (gnomAD). Loss of DSP function is a known mechanism of disease (clinicalgenome.org). Based on the available evidence, this variant is classified as Likely Pathogenic. - |
Arrhythmogenic right ventricular dysplasia 8;C1854063:Arrhythmogenic cardiomyopathy with wooly hair and keratoderma Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 03, 2024 | This sequence change creates a premature translational stop signal (p.Gln90*) in the DSP gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DSP are known to be pathogenic (PMID: 20716751, 24503780, 25227139). This variant is present in population databases (no rsID available, gnomAD 0.006%). This premature translational stop signal has been observed in individual(s) with DSP-related conditions (PMID: 32372669). ClinVar contains an entry for this variant (Variation ID: 265102). For these reasons, this variant has been classified as Pathogenic. - |
Cardiovascular phenotype Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | May 10, 2024 | The p.Q90* pathogenic mutation (also known as c.268C>T), located in coding exon 2 of the DSP gene, results from a C to T substitution at nucleotide position 268. This changes the amino acid from a glutamine to a stop codon within coding exon 2. This variant was detected in a sudden death case for which autopsy findings showed evidence of cardiomyopathy (Rueda M et al. Front Cardiovasc Med, 2017 Nov;4:72). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). Alterations in DSP that result in haploinsufficiency or protein truncation have been reported in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC) and dilated cardiomyopathy (DCM) (Fressart V et al. Europace. 2010;12(6):861-8; Elliott P et al. Circ Cardiovasc Genet. 2010;3(4):314-22; Quarta G et al. Circulation. 2011;123(23):2701-9; Garcia-Pavia P et al. Heart. 2011;97(21):1744-52; Rasmussen TB et al. Clin Genet. 2013;84(1):20-30; Pugh TJ et al. Genet Med. 2014;16(8):601-8). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
Vest4
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at